Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AstraZeneca PLC ADR

AZN
Current price
72.66 USD -0.08 USD (-0.11%)
Last closed 70.94 USD
ISIN US0463531089
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 202 626 170 880 USD
Yield for 12 month +18.32 %
1Y
3Y
5Y
10Y
15Y
AZN
21.11.2021 - 28.11.2021

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

88.01 USD

P/E ratio

31.57

Dividend Yield

2.27 %

Current Year

+45 811 000 000 USD

Last Year

+44 351 000 000 USD

Current Quarter

+13 565 000 000 USD

Last Quarter

+12 938 000 000 USD

Current Year

+37 771 000 000 USD

Last Year

+31 960 000 000 USD

Current Quarter

+10 484 000 000 USD

Last Quarter

+9 793 000 000 USD

Key Figures AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 18 390 999 040 USD
Operating Margin TTM 20.40 %
PE Ratio 31.57
Return On Assets TTM 8.50 %
PEG Ratio 0.71
Return On Equity TTM 16.66 %
Wall Street Target Price 88.01 USD
Revenue TTM 51 206 000 640 USD
Book Value 26.27 USD
Revenue Per Share TTM
Dividend Share 2.97 USD
Quarterly Revenue Growth YOY 18.00 %
Dividend Yield 2.27 %
Gross Profit TTM 35 732 000 000 USD
Earnings per share 2.07 USD
Diluted Eps TTM 2.07 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 3.40 %
Profit Margin 12.68 %

Dividend Analytics AZN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

6.00 %

Consecutive Years

1 year

5Y Average Payout Ratio

-742.00 %

Dividend History AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.49
Ex Dividend Date 09.08.2024
Forward Annual Dividend Yield 2.27 %
Last Split Factor 2:1
Payout Ratio 46.30 %
Last Split Date 27.07.2015
Dividend Date 09.09.2024

Stock Valuation AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 31.57
Forward PE 13.97
Enterprise Value Revenue 4.47
Price Sales TTM 3.96
Enterprise Value EBITDA 15.38
Price Book MRQ 4.98

Financials AZN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AZN

For 52 weeks

59.19 USD 87.68 USD
50 Day MA 69.23 USD
Shares Short Prior Month 8 065 227
200 Day MA 74.95 USD
Short Ratio 0.92
Shares Short 7 397 014
Short Percent 0.24 %